In the Karagiannis et al. human xenograft model of a patient-derived ovarian carcinoma in immunocompromised mice, the survival benefit provided through treatment with MOv18 IgE was abrogated when engrafted human PBMCs were depleted of monocytes [42]. Here, IGHE is linked to ovarian carcinoma.